期刊
CANCERS
卷 14, 期 24, 页码 -出版社
MDPI
DOI: 10.3390/cancers14246071
关键词
androgen receptor; prostate cancer; resistance mechanisms; androgen receptor signaling inhibitors; antiandrogens
类别
This review provides an overview of the current state of androgen inhibition in the treatment of advanced prostate cancer and discusses the mechanisms of resistance to approved antiandrogen drugs. It also summarizes the main research approaches in the field of androgen receptor inhibition to overcome resistance and explores potential new drugs under investigation.
The androgen signaling pathway is the cornerstone in the treatment of high risk or advanced prostate cancer patients. However, in recent years, different mechanisms of resistance have been defined in this field, limiting the efficacy of the currently approved antiandrogen drugs. Different therapeutic approaches are under research to assess the role of combination therapies against escape signaling pathways or the development of novel antiandrogen drugs to try to solve the primary or acquired resistance against androgen dependent or independent pathways. The present review aims to summarize the current state of androgen inhibition in the therapeutic algorithm of patients with advanced prostate cancer and the mechanisms of resistance to those available drugs. In addition, this review conducted a comprehensive overview of the main present and future research approaches in the field of androgen receptor inhibition to overcome these resistances and the potential new drugs under research coming into this setting.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据